权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular and Cellular Immunology Core

分子和细胞免疫学核心

基本信息

批准号：
10576206
负责人：
George S Hui
金额：
$ 19.35万
依托单位：
UNIVERSITY OF HAWAII AT MANOA
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-03-14 至 2023-07-13
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10576206
关键词：
Affect Africa Asia Back Biomedical Research Biotechnology Burn injury Businesses Caliber Cell Separation Cellular Immunology Centers of Research Excellence Climate Collaborations Communities Core Facility Custom Discipline Effectiveness Elements Emerging Communicable Diseases Ensure Equipment Evaluation Extramural Activities Fees Flow Cytometry Fostering Funding Goals Grant Hawaii Health Hospitals Human Resources Immunologics Infectious Disease Immunology Infectious Diseases Research Infrastructure Institution International Maintenance Marketing Mentors Mission Molecular Immunology Monitor Needs Assessment Periodicity Phase Phase Transition Principal Investigator Productivity Publications Research Research Infrastructure Research Personnel Research Training Resource Allocation Resources Role Schedule Science Scientific Inquiry Scientist Services Stream Structure Surveys System Techniques Training Training Programs Training and Education Triad Acrylic Resin Universities base effectiveness evaluation improved laboratory experience medical schools operation outreach programs prospective research and development satisfaction skills success tool

项目摘要

Project Summary for the Molecular and Cellular Immunology Core As the singular research resource for flow cytometry, cell sorting and myriad immunological services at the University of Hawaii (UH) and in the entire State of Hawaii, the Molecular and Cellular Immunology (MCI) Core has had a significant impact on increasing research productivity, enhancing research competitiveness and heightening grants success during COBRE Phases I and II. Extramurally funded research is heavily dependent on the MCI Core, and the need is anticipated to grow during and beyond the Phase III COBRE period. The Phase III COBRE objective of facilitating the transition of the MCI Core into a sustainable state-of-the-art core facility capable of supporting high-caliber research on new, emerging and re-emerging infectious diseases, as well as other fields of scientific inquiry, will be achieved by (1) enhancing and streamlining core operations; (2) growing and diversifying the user base, capability, capacity and reach; and (3) strengthening the core infrastructure. For Aim 1, needs assessments and user satisfaction surveys will be conducted to ensure efficiency and effectiveness of core operations. Also, mentoring and training of current and prospective users will be better integrated, and partnerships will be formed with research training programs in infectious diseases and immunology. For Aim 2, outreach and marketing activities will be expanded to other local academic institutions, biotech companies and hospitals beyond the UH System, and strong partnerships will be formed with similar cores located in other COBRE, INBRE and IDeA-CTR programs to grow and diversify the core user base and to acquire new tools and techniques. Also, the MCI Core will leverage the existing infrastructure of research training laboratories in the Asia-Pacific region to facilitate international collaborative research. And for Aim 3, sustainability and phased-in business plans will be developed during the Phase III COBRE period to draw on multiple avenues of intramural and extramural support to sustain the Core. Periodic evaluation and review of the Core's fiscal health will allow necessary restructuring of the key elements affecting solvency to guide efforts to sustain the Core beyond Phase III COBRE support. The MCI Core is expected to achieve each of the above-stated specific aims. A strong commitment of $50,000 per year for five years beyond the Phase III COBRE period, by the JABSOM Dean, will provide an important hedge against uncertain revenue streams during this competitive and uncertain funding climate and will ensure continued core operations, with the prospect of increased grants success and core sustainability.

分子和细胞免疫学核心项目总结